Fontenay Sous Bois, France

Emilia Pisani

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Emilia Pisani: Innovator in Cancer Treatment

Introduction

Emilia Pisani is a notable inventor based in Fontenay Sous Bois, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic approaches. Her work focuses on improving the efficacy and safety of cancer therapies, particularly for hepatocellular carcinoma.

Latest Patents

Emilia Pisani holds a patent for "Nanoparticles loaded with chemotherapeutic antitumoral drug." This invention relates to new therapeutic approaches for treating cancer, specifically targeting hepatocellular carcinoma. The patented technology involves the administration of nanoparticles loaded with a chemotherapeutic agent via intravenous infusion for at least two hours. This method aims to prevent toxicological side effects and enhance the benefit/risk ratio of the treatment. She has 1 patent to her name.

Career Highlights

Throughout her career, Emilia has worked with various companies, including Onxeo S.A. and Onxeo. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research in cancer therapies.

Collaborations

Emilia has collaborated with notable colleagues such as Sophie Lebel-Binay and Valérie Polard. These partnerships have played a crucial role in advancing her research and developing innovative solutions for cancer treatment.

Conclusion

Emilia Pisani is a pioneering inventor whose work in cancer treatment is making a significant impact. Her innovative approach to using nanoparticles for chemotherapy represents a promising advancement in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…